Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non–Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants- A Phase 2 Randomized Clinical Trial N Bi et al, JAMA Network Open, December 18, 2019

Hot Topics of the Day|PHGKB


Last Posted: Dec 19, 2019

---

• Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non–Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants- A Phase 2 Randomized Clinical Trial
  N Bi et al, JAMA Network Open, December 18, 2019
• Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
  Byeon Seonggyu et al. Clinical lung cancer 2019 Nov
• Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In China.
  You Ruxu et al. Cancer management and research 2019 1110239-10248
• Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
  Tan Aaron C et al. Lung cancer (Amsterdam, Netherlands) 2019 Nov 139207-215
• Artificial intelligence applications for thoracic imaging.
  Chassagnon Guillaume et al. European journal of radiology 2019 Dec 123108774
• Eliminating biasing signals in lung cancer images for prognosis predictions with deep learning.
  van Amsterdam W A C et al. NPJ digital medicine 2019 2122
• Noncoding RNAs and Liquid Biopsy in Lung Cancer: A Literature Review.
  Harangu? Antonia et al. Diagnostics (Basel, Switzerland) 2019 Dec 9(4)
• Ultra-deep massively parallel sequencing with unique molecular identifier tagging achieves comparable performance to droplet digital PCR for detection and quantification of circulating tumor DNA from lung cancer patients.
  Tran Le Son et al. PloS one 2019 14(12) e0226193
• Circulating tumour DNA as a cancer biomarker.
  Duffy Michael J et al. Annals of clinical biochemistry 2019 56(1) 42-48
• Natural language processing for populating lung cancer clinical research data.
  Wang Liwei et al. BMC medical informatics and decision making 2019 Dec 19(Suppl 5) 239

more